$2.07 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 81 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 41.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Sell | GILEAD SCIENCES INC | $149,435,000 | -17.1% | 1,626,764 | -8.7% | 7.22% | -6.0% |
| ALXN | Sell | ALEXION PHARM INC | $91,469,000 | -36.8% | 657,013 | -13.3% | 4.42% | -28.3% |
| REGN | Sell | REGENERON PHARMCTCLS | $83,900,000 | -34.6% | 232,770 | -1.5% | 4.06% | -25.8% |
| BIIB | Sell | BIOGEN INC | $61,064,000 | -31.5% | 234,572 | -19.4% | 2.95% | -22.3% |
| TMO | Sell | THERMO FISHER SCI | $52,442,000 | -39.1% | 370,376 | -39.0% | 2.54% | -30.9% |
| MRK | Sell | MERCK & CO INC | $39,678,000 | -33.0% | 749,914 | -33.2% | 1.92% | -24.1% |
| LLY | Sell | ELI LILLY & CO | $36,487,000 | -27.7% | 506,695 | -15.4% | 1.76% | -18.1% |
| MDT | Sell | MEDTRONIC PLC | $35,695,000 | -14.7% | 475,931 | -12.5% | 1.73% | -3.2% |
| MYL | Sell | MYLAN N V | $27,329,000 | -16.0% | 589,627 | -2.0% | 1.32% | -4.8% |
| TEVA | Sell | TEVA PHARMACEUTICALadr | $27,242,000 | -31.5% | 509,110 | -16.0% | 1.32% | -22.3% |
| UNH | Sell | UNITEDHEALTH GRP INC | $22,634,000 | -8.2% | 175,590 | -16.2% | 1.09% | +4.0% |
| STJ | Sell | ST JUDE MEDICAL INC | $18,402,000 | -25.0% | 334,584 | -15.8% | 0.89% | -14.9% |
| ISRG | Sell | INTUITIVE SURGIC INC | $14,045,000 | -17.1% | 23,367 | -24.7% | 0.68% | -6.1% |
| NVO | Sell | NOVO-NORDISK ASadr | $11,715,000 | -27.2% | 216,175 | -22.0% | 0.57% | -17.5% |
| EW | Sell | EDWARDS LIFESCIENCE | $9,751,000 | -50.7% | 110,541 | -55.8% | 0.47% | -44.1% |
| NVS | Sell | NOVARTIS AGsp adr | $8,968,000 | -41.6% | 123,805 | -30.6% | 0.43% | -33.6% |
| RDY | Sell | DR REDDYS LABS LTDadr | $4,162,000 | -26.0% | 92,105 | -24.2% | 0.20% | -16.2% |
| AGN | Sell | ALLERGAN PLC | $2,849,000 | -54.8% | 10,631 | -47.4% | 0.14% | -48.7% |
| PRGO | Sell | PERRIGO CO | $2,179,000 | -49.5% | 17,030 | -42.9% | 0.10% | -42.9% |
| MNKKQ | Sell | MALLINCKRODT PLC | $1,683,000 | -57.6% | 27,467 | -48.3% | 0.08% | -52.1% |
| AKRXQ | Sell | AKORN INC | $794,000 | -67.0% | 33,744 | -47.6% | 0.04% | -62.7% |
| AMPH | Sell | AMPHASTAR PHARMACTLS | $467,000 | -54.9% | 38,905 | -46.5% | 0.02% | -47.7% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $175,000 | -92.4% | 12,760 | -90.7% | 0.01% | -91.9% |
| IRWD | Sell | IRONWOOD PHARMACEUCL | $117,000 | -87.7% | 10,725 | -86.9% | 0.01% | -85.0% |
| CHRS | Exit | COHERUS BIOSCIENCES | $0 | – | -15,940 | -100.0% | -0.02% | – |
| CBM | Exit | CAMBREX CORP | $0 | – | -25,231 | -100.0% | -0.05% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -61,234 | -100.0% | -0.06% | – |
| DEPO | Exit | DEPOMED INC | $0 | – | -93,183 | -100.0% | -0.07% | – |
| JAZZ | Exit | JAZZ PHARMA PLC | $0 | – | -13,550 | -100.0% | -0.08% | – |
| ENDP | Exit | ENDO INTL PLCshares | $0 | – | -31,062 | -100.0% | -0.08% | – |
| EGRX | Exit | EAGLE PHARMACEUTIC | $0 | – | -21,899 | -100.0% | -0.08% | – |
| IPXL | Exit | IMPAX LABS INC | $0 | – | -47,031 | -100.0% | -0.09% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -10,401 | -100.0% | -0.09% | – |
| ALKS | Exit | ALKERMES PLCshares | $0 | – | -25,895 | -100.0% | -0.09% | – |
| Exit | REGENXBIO INC | $0 | – | -156,741 | -100.0% | -0.13% | – | |
| CMRX | Exit | CHIMERIX INC | $0 | – | -550,100 | -100.0% | -0.21% | – |
| CI | Exit | CIGNA CORP | $0 | – | -57,104 | -100.0% | -0.36% | – |
| HTWR | Exit | HEARTWARE INTL INC | $0 | – | -204,008 | -100.0% | -0.44% | – |
| UTHR | Exit | UNITED THERAPEUTICS | $0 | – | -195,280 | -100.0% | -1.30% | – |
| HALO | Exit | HALOZYME THERAPEUTIC | $0 | – | -2,075,796 | -100.0% | -1.53% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -1,275,775 | -100.0% | -2.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.